Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio

PARIS & BOSTON & LONDON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, and V7, a leading AI and data labeling company, today announced their partnership to develop a cutting-edge infrastructure for AI applications with Cellvizio. Mauna Kea and V7 will collaborate to establish a strategic data repository of clinically-augmented, curated and an